First Time Loading...

Prothena Corporation PLC
NASDAQ:PRTA

Watchlist Manager
Prothena Corporation PLC Logo
Prothena Corporation PLC
NASDAQ:PRTA
Watchlist
Price: 22.93 USD 4.04% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

PRTA Price Targets Summary
Prothena Corporation PLC

Wall Street analysts forecast PRTA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRTA is 68.1 USD with a low forecast of 34.34 USD and a high forecast of 98.7 USD.

PRTA Lowest Forecast
Wall Street Target
34.34 USD
50% Upside
PRTA Average Forecast
Wall Street Target
68.1 USD
197% Upside
PRTA Highest Forecast
Wall Street Target
98.7 USD
330% Upside
Lowest
Price Target
34.34 USD
50% Upside
Average
Price Target
68.1 USD
197% Upside
Highest
Price Target
98.7 USD
330% Upside
Prothena Corporation PLC Competitors:
Price Targets
B
300289
Beijing Leadman Biochemistry Co Ltd
264% Upside
PANACEABIO
Panacea Biotec Ltd
51% Downside
4142
Adimmune Corp
27% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
78% Upside
B
300289
Beijing Leadman Biochemistry Co Ltd
264% Upside
PANACEABIO
Panacea Biotec Ltd
51% Downside
4142
Adimmune Corp
27% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
78% Upside
AGIO
Agios Pharmaceuticals Inc
26% Upside
FHTX
Foghorn Therapeutics Inc.
134% Upside
PHM
Pharma Mar SA
70% Upside
GLPG
Galapagos NV
55% Upside

Revenue
Forecast

Revenue Estimate
Prothena Corporation PLC

For the last 8 years the compound annual growth rate for Prothena Corporation PLC's revenue is 66%. The projected CAGR for the next 3 years is 31%.

66%
Past Growth
31%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Prothena Corporation PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Prothena Corporation PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss
What are analyst estimates?

See Also

Summary
PRTA intrinsic value, competitors valuation, and company profile.
DCF Valuation
PRTA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PRTA stock valuation using valuation multiples.
Wall Street Estimates
PRTA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PRTA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRTA's stock price target?
Price Target
68.1 USD

According to Wall Street analysts, the average 1-year price target for PRTA is 68.1 USD with a low forecast of 34.34 USD and a high forecast of 98.7 USD.

What is Prothena Corporation PLC's Revenue forecast?
Projected CAGR
31%

For the last 8 years the compound annual growth rate for Prothena Corporation PLC's revenue is 66%. The projected CAGR for the next 3 years is 31%.

ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.